Sulfamide

Sulfamide

SCHEMBL5880

NS(N)(=O)=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfamide SCHEMBL10866319 0.93
Sulfamide SCHEMBL3827754 0.93
Sulfamide SCHEMBL1000467 0.93
Sulfamide SCHEMBL5067852 0.93
Sulfamide SCHEMBL17495597 0.93
Sulfamide SCHEMBL3293102 0.93
Sulfamide SCHEMBL3409127 0.93
Sulfamide SCHEMBL5667325 0.93
Sulfamide SCHEMBL10866317 0.93
Sulfamide SCHEMBL28401925 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 54293 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6423486-B1 None US claimed
US-20260144795-A1 SPIROMACROCYCLIC OREXIN 2 RECEPTOR AGONISTS H. LUNDBECK A/S (DK) 2026-05-28 US claimed
WO-2026088050-A1 SMALL MOLECULE INHIBITOR OF FOXA1 AND FOXA2 FOR THE TREATMENT OF FOXA1/FOXA2-DEPENDENT CANCERS OR OTHER DISEASES FONDAZIONE PER L'ISTITUTO ONCOLOGICO DI RICERCA (IOR) (CH) 2026-04-30 WO claimed
WO-2026090139-A1 ANTI-LY6K ANTIBODY-DRUG CONJUGATES AND METHODS OF USE NORMUNITY, INC. (US) 2026-04-30 WO claimed
US-20260108620-A1 ANTIBODY-CONJUGATES FOR TARGETING OF TUMOURS EXPRESSING TROP-2 SYNAFFIX BV (NL) 2026-04-23 US claimed
US-20260103499-A1 BIOREVERSABLE PROMOIETIES FOR NITROGEN-CONTAINING AND HYDROXYL-CONTAINING DRUGS HAN JIE (US) 2026-04-16 US claimed
EP-4724074-A1 COMPOSITIONS AND METHODS FOR TREATING HYPERINSULINEMIC HYPOGLYCEMIA Vogenx (US) 2026-04-15 EP claimed
EP-4724429-A1 SGLT1 INHIBITOR AND INCRETIN COMBINATIONS FOR TREATING METABOLIC DISEASE Vogenx (US) 2026-04-15 EP claimed
US-12600705-B2 Heat shock protein modulators and anti-Huntington disease therapeutic agents UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2026-04-14 US claimed
EP-4719397-A1 USE OF AN OREXIN 2 RECEPTOR AGONIST FOR IMPROVING RESPIRATORY FUNCTION DURING SLEEP Takeda Pharmaceutical Company Limited (JP) 2026-04-08 EP claimed
US-3998828-A ORAL HYPOGLYCEMIC AGENTS PFIZER INC. (US) 1976-12-21 US claimed
US-3994897-A Process for the manufacture of carboxylic acids from methyl ketones BASF AKTIENGESELLSCHAFT (DT) 1976-11-30 US claimed
US-3992444-A BY REACTION OF A SULFAMIC ACID WITH AN ACID HALIDE BASF AKTIENGESELLSCHAFT (DT) 1976-11-16 US claimed
US-3991108-A PRODUCTION OF ACYL AND CARBAMOYL FLUORIDES AND THEIR CORRESPONDING ISOCYANATES JORDAN ROBERT KENNETH 1976-11-09 US claimed
US-3985718-A AN OXIDIZING AGENT, A CHELATE COMPOUND, AN ELECTRON DONOR AND A CHELATING COMPLEX RHONE-POULENC S.A. (FR) 1976-10-12 US claimed
US-3984406-A FROM AN ALKALI METAL PHTHALAMATE AND A HYPOHALITE IN A HALOGEN CATALYST BASF AKTIENGESELLSCHAFT (DT) 1976-10-05 US claimed
US-3980427-A MONOAZO OR DISAZO DYE, HALOGENATED HYDROCARBON BAYER AKTIENGESELLSCHAFT (DT) 1976-09-14 US claimed
US-3961884-A Process for dyeing textile material of polyester fiber/cellulose blends HOECHST AKTIENGESELLSCHAFT (DT) 1976-06-08 US claimed
US-3961024-A Fluoro compound production ALLIED CHEMICAL CORPORATION (US) 1976-06-01 US claimed
US-3944524-A ORAL HYPOGLYCEMIC AGENTS PFIZER INC. (US) 1976-03-16 US claimed